New drug shows promise for lupus brain fog in landmark trial
Disease control
Completed
This study tested an experimental drug called EG-501 for people with lupus who experience cognitive impairment, often called "brain fog." The trial involved 131 participants who received either the drug or a placebo for 14 weeks. The goal was to see if EG-501 could safely improve…
Phase: PHASE2 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC